Cardiovascular Screening

An integrated cardiovascular risk panel combining the full lipid profile with fasting glucose and kidney function markers. Provides a broader cardiovascular assessment than the standalone cholesterol panel by adding metabolic and renal parameters that independently influence heart disease risk.

Cardiovascular risk is multifactorial, and a lipid profile alone — while essential — captures only one dimension. This panel expands the assessment by adding fasting glucose and kidney function markers, both of which are independent risk factors for cardiovascular events and are included in major European risk scoring models. Fasting glucose identifies early blood sugar dysregulation, including prediabetes, which approximately doubles the risk of cardiovascular disease even before a formal diabetes diagnosis. Kidney function — assessed through creatinine and estimated glomerular filtration rate (eGFR) — is relevant because reduced renal clearance accelerates atherosclerosis and is associated with elevated blood pressure and altered lipid metabolism. The combination of lipid, glucose, and renal markers provides a more complete risk picture than any single domain alone. This panel is positioned between the standalone cholesterol test and the general health screening in both scope and price. It is well suited for individuals with a family history of heart disease, those with borderline cholesterol results who want additional metabolic context, or anyone seeking a focused cardiovascular risk assessment without the breadth of a full general screening. Fasting is recommended for accurate glucose and triglyceride measurement — no food for 10 to 12 hours before the draw, with water permitted.